What Is Ozempic 0.25mg?
Ozempic 0.25mg is the introductory dose of semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes management and now widely used for chronic weight management. The 0.25mg dose is not a therapeutic weight loss dose, it is a titration dose, meaning its primary purpose is to help your body acclimate to semaglutide before stepping up to higher doses.
Most prescribing guidelines recommend staying at 0.25mg for four weeks before advancing to 0.5mg. This stepped approach significantly reduces the likelihood of nausea, vomiting, and gastrointestinal side effects that are common when starting GLP-1 therapy.
How Ozempic 0.25mg Works
Semaglutide mimics GLP-1, a naturally occurring hormone released after eating. At the 0.25mg dose, it begins:
- Signaling the pancreas to release insulin in response to meals
- Slowing gastric emptying, which extends the feeling of fullness
- Reducing appetite signals in the brain
- Stabilizing blood sugar fluctuations after eating
At this introductory dose, weight loss effects are typically minimal. Most patients report reduced appetite and some early changes in food cravings. The meaningful weight loss associated with Ozempic occurs at the 0.5mg, 1mg, and 2mg therapeutic doses.
Who Is the 0.25mg Starting Dose For?
The 0.25mg dose is appropriate for:
- Anyone beginning semaglutide therapy for the first time
- Patients restarting Ozempic after a break of more than two weeks
- Individuals who experienced significant side effects at a higher dose and have stepped back down under medical guidance
It is not intended as a long-term maintenance dose. If you have been on semaglutide therapy before and are restarting, your provider may recommend returning to 0.25mg for the first four weeks before re-escalating.
What to Expect in the First Four Weeks
Most people starting Ozempic 0.25mg report the following progression:
Week 1: Injection site reactions are possible (mild redness, slight swelling). Some patients notice mild nausea, particularly after the first injection. Appetite may begin to decrease.
Week 2: The body begins adjusting to semaglutide’s effects. Nausea typically lessens. Reduced appetite and slower gastric emptying become more noticeable.
Week 3-4: Most patients report consistent appetite reduction. Energy levels may shift as caloric intake naturally decreases. GI symptoms, if present, usually stabilize.
Early weight changes at this dose are modest, typically 1-3 lbs over four weeks. The 0.25mg dose is preparation, not the primary driver of results.
Most patients notice a meaningful difference in appetite suppression when they move from 0.25mg to 0.5mg. If you are still experiencing significant nausea at week four, discuss with your provider whether to advance the dose or extend the titration period.
How to Inject Ozempic 0.25mg
- Remove the pen from the refrigerator 30 minutes before injecting room temperature injections are more comfortable
- Check the solution it should be clear and colorless. Do not use if cloudy or discolored
- Attach a new needle to the pen for each injection
- Select an injection site: abdomen (at least 2 inches from the navel), outer thigh, or upper arm
- Pinch the skin lightly, insert the needle at a 90-degree angle, and press the injection button
- Hold for 6 seconds after pressing to ensure the full dose is delivered
- Remove the needle and dispose of it in a sharps container
- Rotate injection sites each week to avoid tissue buildup
Storage Instructions
- Before first use: Store in the refrigerator at 36°F-46°F (2°C–8°C)
- After first use: Can be stored at room temperature (up to 77°F / 25°C) or continued in the refrigerator for up to 56 days
- Never freeze. Never expose to direct heat or sunlight
- Keep the pen cap on when not in use
- Do not store with the needle attached
Common Side Effects at 0.25mg
The 0.25mg dose is specifically designed to minimize side effects while introducing semaglutide to the body. Most commonly reported:
- Nausea (most common, typically mild at this dose)
- Reduced appetite
- Mild fatigue during the first week
- Injection site reactions (redness, minor bruising)
- Occasional constipation or loose stools
Serious side effects are rare but include pancreatitis, gallbladder disease, and severe allergic reactions. Discontinue use and seek medical attention immediately if you experience severe abdominal pain, persistent vomiting, or signs of allergic reaction.
Frequently Asked Questions
How long do I stay on Ozempic 0.25mg?
The standard titration period is four weeks. After four weeks at 0.25mg, most prescribing guidelines recommend advancing to 0.5mg. Some patients with significant nausea may extend the titration period at their provider’s direction.
Will I lose weight on the 0.25mg dose?
Modest weight loss is possible, but 0.25mg is primarily a titration dose, not a therapeutic weight loss dose. Meaningful weight loss on semaglutide typically begins at the 0.5mg dose and increases with each escalation.
Can I skip the 0.25mg dose and start at 0.5mg?
This is not recommended. Starting at a higher dose significantly increases the risk of nausea, vomiting, and GI discomfort. The four-week titration at 0.25mg exists specifically to minimize these side effects.
Is Ozempic 0.25mg the same as Wegovy 0.25mg?
Both contain semaglutide at 0.25mg, and both use a similar titration protocol. Ozempic is FDA-approved for type 2 diabetes management, while Wegovy is FDA-approved specifically for weight management. The active ingredient and starting dose are identical.
How do I know the pen is empty?
The injection counter on the Ozempic pen counts down with each dose. When it reaches zero and the plunger is fully depressed with no resistance, the pen is empty. Never attempt to use an empty pen.
What if I miss a dose?
If you miss a dose and your next scheduled injection is more than two days away, inject as soon as you remember. If your next scheduled injection is within two days, skip the missed dose and continue your regular schedule. Never inject two doses to make up for a missed one.
Related Products
- Ozempic 0.5mg: First therapeutic dose, for weeks 5–8
- Ozempic 1mg: Standard maintenance dose for weight management
This product description is for informational purposes only. Ozempic requires a valid prescription in the United States. Consult a licensed healthcare provider before beginning semaglutide therapy.


